PPF Group logo

PPF Group

Europe, Noord-Holland, The Netherlands, Amsterdam

Description

PPF Group invests into multiple market segments across Europe, Russia, the US and Asia.

Investor Profile

PPF Group has made 23 investments, with 1 in the past 12 months and 65% as lead.

Stage Focus

  • Series Unknown (39%)
  • Series B (17%)
  • Series A (13%)
  • Series C (9%)
  • Post Ipo Equity (9%)
  • Seed (4%)
  • Private Equity (4%)
  • Post Ipo Secondary (4%)

Country Focus

  • United Kingdom (39%)
  • Switzerland (26%)
  • France (9%)
  • United States (4%)
  • Sweden (4%)
  • Germany (4%)
  • Luxembourg (4%)
  • Serbia (4%)
  • Czech Republic (4%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Banking
  • Financial Services
  • Fintech
  • Medical
  • Oncology
  • Biopharma
  • Payments
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does PPF Group frequently co-invest with?

EV
North America, Maryland, United States, Rockville
Co-Investments: 1
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 2
Sotio
Europe, Hlavni mesto Praha, Czech Republic, Prague
Co-Investments: 1
CFFI Ventures
North America, Saint Michael, Barbados, Bridgetown
Co-Investments: 2
Apax Digital
North America, New York, United States, New York
Co-Investments: 1
Boehringer Ingelheim
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 1
GoBeyond
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
FC Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Emerging Technology Partners
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does PPF Group often collaborate with?

PS
Europe, Zurich, Switzerland
Shared Deals: 1
John Risley
North America, Nova Scotia, Canada, Bedford
Shared Deals: 1

What are some of recent deals done by PPF Group?

Mobi Banka

Novi Beograd, Vojvodina, Serbia

Mobi Banka offers personal banking, current accounts, credit cards, currency exchange and commercial lending solutions.

BankingCredit CardsFinanceFinancial ServicesFinTechLendingMobile Apps
Series UnknownApr 25, 2024
Amount Raised: $35,398,268
Flash Pack

London, England, United Kingdom

Flash Pack is an award-winning adventure travel company that brings together solo travelers in their 30s and 40s.

TourismTravel
Series UnknownOct 23, 2023
Amount Raised: $6,124,621
InPost

Luxembourg, Luxembourg, Luxembourg

InPost operates as an automated parcel machine (APM) service provider.

DeliveryLast Mile TransportationLogisticsSelf-Storage
Post Ipo SecondaryMay 26, 2023
ProSiebenSat.1 Media

Unterföhring, Bayern, Germany

ProSiebenSat.1 Media SE is a mass media company operating television, radio stations and print businesses.

AdvertisingBroadcastingMedia and EntertainmentMusic
Post Ipo EquityFeb 21, 2023
ClearBank

Bristol, Bristol, City of, United Kingdom

ClearBank is a clearing and agency banking platform allowing banks and other customers real-time clearance on payment transactions.

BankingFinancial ServicesFinTechPayments
Private EquityMar 18, 2022
Amount Raised: $230,685,069
Sotio

Prague, Hlavni mesto Praha, Czech Republic

Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownDec 2, 2021
Amount Raised: $316,567,683
Navigare Yachting

Malmö, Skane Lan, Sweden

Navigare Yachting is a yacht charter operator that provides tourism and transport services.

Marine TransportationSalesTour Operator
Series UnknownJul 29, 2021
Culture Trip

London, England, United Kingdom

Premium small-group adventures for like-minded travellers; your companion for exploring the world while being good to it

ContentTravel
Series CAug 25, 2020
Amount Raised: $44,709,722
NBE-Therapeutics

Basel, Basel-Stadt, Switzerland

NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series CJan 10, 2020
Amount Raised: $22,000,000
Cellestia

Basel, Basel-Stadt, Switzerland

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

BiopharmaBiotechnologyHealth CareTherapeutics
Series BDec 17, 2019
Amount Raised: $20,408,705